Novel Common Femoral Artery Lesion Classification in Patients Undergoing Endovascular Revascularization

Rabellino, Martín; Raleigh, Juan Valle; Chiabrando, Juan Guido; Di, Vanesa; Chas, J.; Garagoli, Fernando; Bluro, Ignacio

doi:10.1007/s00270-021-03011-z

Cited by 9 publications

(9 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our evaluation, there was no significant difference regarding TLR between the different lesion groups according to Rabellinio et al [ 11 ]; in particular, bifurcation lesions did not result in inferior outcomes as compared to lesions limited to the CFA main stem.…”

Section: Discussionmentioning

confidence: 46%

“…Applying the Rabellino classification [ 11 ], there was no difference regarding TLR after subdivision into group I/II and the groups with bifurcation involvement (III/IV) as shown in Figure 4 .…”

Section: Resultsmentioning

confidence: 99%

“…Patients treated with other interventional techniques such as plain balloon angioplasty and atherectomy without final stent placement were excluded. CFA lesions were categorized according to the new classification of Rabellino, et al [ 11 ].…”

Section: Methodsmentioning

confidence: 99%

“… Kaplan–Meier curve for TLR-free survival for patients with lesions with and without bifurcation involvement. TLR—target lesion revascularization, I–IV; classification according to Rabellinio [ 11 ]. …”

Section: Figurementioning

confidence: 99%

See 3 more Smart Citations

Evaluation of Stent Angioplasty in the Treatment of Arteriosclerotic Lesions of the Common Femoral Artery

Böhme

Zeller

Abboud

et al. 2022

JCM

View full text Add to dashboard Cite

In many vascular segments, endovascular therapy is the treatment of choice for arteriosclerotic lesions. For the treatment of common femoral artery (CFA) lesions, surgical reconstruction is still considered the gold standard. The purpose of this study is to evaluate the safety and efficacy of stent angioplasty for the treatment of common femoral artery (CFA) lesions in a real-world population during a two-year follow up. This retrospective, single-center study includes 250 patients requiring treatment with stent angioplasty of CFA lesions. The primary end point was the target lesion revascularization (TLR) rate. Secondary end points were the overall procedural complication rate, the rate of ipsilateral CFA punctures during follow-up, changes in the Rutherford–Becker class (RBC) and ankle–brachial index (ABI), primary patency rates, amputation rate, time to and the type of TLR. A total of 236 interventions (94.4%) were successfully defined as a residual stenosis < 30%. Periinterventionally, there were 23 complications (9.1%), 3 of which had to be treated surgically. Median follow up was 21 months (average 19.2 ± 7.8). In total, 41 patients (16.4%) needed a TLR. The primary patency rate was 90.8%, 81.2% and 72% at 6, 12 and 24 months, respectively. ABI and RBC were significantly better at all time points compared to baseline. During follow up, seven amputations (three minor and four major) had to be performed. More than half of the patients (56.0%) were punctured at the stented CFA during the follow up. Multivariate logistic regression analysis showed continued nicotine use and coronary heart disease as predictors for TLR. Stent angioplasty for the treatment of CFA lesions is safe and effective. Further studies are needed to compare this endovascular option with surgical therapy.

show abstract

Section: Discussionmentioning

confidence: 46%

Section: Resultsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Figurementioning

confidence: 99%

See 2 more Smart Citations

Evaluation of Stent Angioplasty in the Treatment of Arteriosclerotic Lesions of the Common Femoral Artery

Böhme

Zeller

Abboud

et al. 2022

JCM

View full text Add to dashboard Cite

show abstract

“…In the present study, Rabellino et al modified the Azema classification in a very practical way [4]: Previous Type IV lesions defined as bypass stenotic lesions were excluded in order to limit the new classification to native artery atherosclerotic lesions. Hence, Type I-III lesions remained the same.…”

mentioning

confidence: 99%

Time for a Standardized Common Femoral Artery Classification System

Zeller

2022

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

show abstract

The Specificities of the Common Femoral Artery Anatomy, Calcification and Treatment

Nasr,

Gouëffic

2024

Mastering Endovascular Techniques

View full text Add to dashboard Cite

Novel Common Femoral Artery Lesion Classification in Patients Undergoing Endovascular Revascularization

Cited by 9 publications

References 22 publications

Evaluation of Stent Angioplasty in the Treatment of Arteriosclerotic Lesions of the Common Femoral Artery

Evaluation of Stent Angioplasty in the Treatment of Arteriosclerotic Lesions of the Common Femoral Artery

Time for a Standardized Common Femoral Artery Classification System

The Specificities of the Common Femoral Artery Anatomy, Calcification and Treatment

Contact Info

Product

Resources

About